{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T08:04:43Z","timestamp":1777449883713,"version":"3.51.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T00:00:00Z","timestamp":1609718400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T00:00:00Z","timestamp":1609718400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiol med"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s11547-020-01317-5","type":"journal-article","created":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T15:12:28Z","timestamp":1609773148000},"page":"707-716","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Distinct MR features in scleroderma associated myopathy"],"prefix":"10.1007","volume":"126","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4437-5237","authenticated-orcid":false,"given":"Shivani","family":"Ahlawat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Paik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filippo","family":"Del Grande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elias S.","family":"Paris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parvinder","family":"Sujlana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura M.","family":"Fayad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,4]]},"reference":[{"key":"1317_CR1","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1002\/art.38098","volume":"65","author":"F van den Hoogen","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J et al (2013) classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative. Arthritis Rheum 65:2737\u20132747","journal-title":"Arthritis Rheum"},{"key":"1317_CR2","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1136\/ard.28.3.281","volume":"28","author":"JM Thompson","year":"1969","unstructured":"Thompson JM, Bluestone R, Bywaters EG et al (1969) Skeletal muscle involvement in systemic sclerosis. Ann Rheum Dis 28:281\u2013288","journal-title":"Ann Rheum Dis"},{"key":"1317_CR3","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.3899\/jrheum.121380","volume":"40","author":"C Muangchan","year":"2013","unstructured":"Muangchan C, Markland J, Robinson D et al (2013) The 15% rule in scleroderma: the frequency of severe organ complications in systemic sclerosis. A systematic review J Rheumatol 40:1545\u20131556","journal-title":"A systematic review J Rheumatol"},{"key":"1317_CR4","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1001\/archneur.1992.00530360094024","volume":"49","author":"L Averbuch-Heller","year":"1992","unstructured":"Averbuch-Heller L, Steiner I, Abramsky O (1992) Neurologic manifestations of progressive systemic sclerosis. Arch Neurol 49:1292\u20131295","journal-title":"Arch Neurol"},{"key":"1317_CR5","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1002\/art.1780240506","volume":"24","author":"SG West","year":"1981","unstructured":"West SG, Killian PJ, Lawless OJ (1981) Association of myositis and myocarditis in progressive systemic sclerosis. Arthritis Rheum 24:662\u2013667","journal-title":"Arthritis Rheum"},{"key":"1317_CR6","first-page":"741","volume":"10","author":"ML Russell","year":"1983","unstructured":"Russell ML, Hanna WM (1983) Ultrastructure of muscle microvasculature in progressive systemic sclerosis: relation to clinical weakness. J Rheumatol 10:741\u2013747","journal-title":"J Rheumatol"},{"key":"1317_CR7","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1196\/annals.1422.029","volume":"1108","author":"B Ranque","year":"2007","unstructured":"Ranque B, Authier FJ, Berezne A et al (2007) Systemic sclerosis\u2013associated myopathy. Ann N Y Acad Sci 1108:268\u2013282","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"1317_CR8","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1097\/BOR.0000000000000024","volume":"26","author":"JJ Paik","year":"2014","unstructured":"Paik JJ, Mammen AL, Wigley FM, Gelber AC (2014) Myopathy in scleroderma, its identification, prevalence, and treatment: lessons learned from cohort studies. Curr Opin Rheumatol 26(2):124\u2013130","journal-title":"Curr Opin Rheumatol"},{"key":"1317_CR9","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3109\/03009742.2013.868512","volume":"43","author":"Jung M, Bonner A, Hudson M, Baron M, Pope J, on behalf of the Canadian Scleroderma Research Group","year":"2014","unstructured":"Jung M, Bonner A, Hudson M, Baron M, Pope J, on behalf of the Canadian Scleroderma Research Group (2014) Myopathy is a poor prognostic feature in systemic sclerosis: results from the Canadian Scleroderma Research Group [CSRG] cohort. Scand J Rheumatol 43:217\u2013220","journal-title":"Scand J Rheumatol"},{"key":"1317_CR10","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/0002-8703(93)90075-K","volume":"125","author":"WP Follansbee","year":"1993","unstructured":"Follansbee WP, Zerbe TR, Medsger TA (1993) Cardiac and skeletal muscle disease in systemic sclerosis [scleroderma]: a high risk association. Am Heart J 125:194\u2013203","journal-title":"Am Heart J"},{"key":"1317_CR11","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s10067-004-0975-7","volume":"24","author":"Y Mimura","year":"2005","unstructured":"Mimura Y, Ihn H, Jinnin M et al (2005) Clinical and laboratory features of scleroderma patients developing skeletal myopathy. Clin Rheumatol 24:99\u2013102","journal-title":"Clin Rheumatol"},{"key":"1317_CR12","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1002\/acr.22870","volume":"68","author":"JJ Paik","year":"2016","unstructured":"Paik JJ, Wigley FM, Mejia AF, Hummers LK (2016) Independent Association of Severity of Muscle Weakness With Disability as Measured by the Health Assessment Questionnaire Disability Index in Scleroderma. Arthritis Care Res [Hoboken] 68:1695\u20131703","journal-title":"Arthritis Care Res [Hoboken]"},{"key":"1317_CR13","doi-asserted-by":"crossref","unstructured":"Paik JJ, Wigley FM, Lloyd TE, Corse AM, Casciola4-Rosen L, Shah AA, Boin F, Hummers LK, Mammen AL (2015) Spectrum of Muscle Histopathologic Findings in Forty-Two Scleroderma Patients With Weakness. Arthritis Care Res [Hoboken]. 67:1416-25.","DOI":"10.1002\/acr.22620"},{"issue":"11","key":"1317_CR14","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1002\/acr.23291","volume":"69","author":"JJ Paik","year":"2017","unstructured":"Paik JJ, Wigley FM, Shah AA, Corse AM, Casciola-Rosen L, Hummers LK, Mammen AL (2017) Fibrosing myopathy in systemic sclerosis associates with higher mortality. Arthritis Care Res [Hoboken] 69(11):1764\u20131770. https:\/\/doi.org\/10.1002\/acr.23291","journal-title":"Arthritis Care Res [Hoboken]"},{"key":"1317_CR15","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1056\/NEJMc1506827","volume":"373","author":"MC Dalakas","year":"2015","unstructured":"Dalakas MC (2015) Inflammatory muscle diseases. N Engl J Med 373:393\u2013394","journal-title":"N Engl J Med"},{"key":"1317_CR16","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1097\/BOR.0b013e3282efdc66","volume":"19","author":"GP Kuo","year":"2007","unstructured":"Kuo GP, Carrino JA (2007) Skeletal muscle imaging and inflammatory myopathies. Curr Opin Rheumatol 19:530\u2013535","journal-title":"Curr Opin Rheumatol"},{"key":"1317_CR17","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/mus.24307","volume":"51","author":"J Van De Vlekkert","year":"2015","unstructured":"Van De Vlekkert J, Maas M, Hoogendijk JE et al (2015) Combining MRI and muscle biopsy improves diagnostic accuracy in subacute-onset idiopathic inflammatory myopathy. Muscle Nerve 51:253\u2013258","journal-title":"Muscle Nerve"},{"key":"1317_CR18","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1136\/annrheumdis-2016-210198","volume":"76","author":"I Pinal-Fernandez","year":"2017","unstructured":"Pinal-Fernandez I, Casal-Dominguez M, Carrino JA et al (2017) Thigh muscle MRI in immune-mediated necrotising myopathy: extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severity. Ann Rheum Dis 76:681\u2013687","journal-title":"Ann Rheum Dis"},{"key":"1317_CR19","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/mus.23911","volume":"49","author":"SD Friedman","year":"2014","unstructured":"Friedman SD, Poliachik SL, Otto RK et al (2014) Longitudinal features of STIR bright signal in FSHD. Muscle Nerve 49:257\u2013260","journal-title":"Muscle Nerve"},{"key":"1317_CR20","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1007\/s00330-012-2584-1","volume":"23","author":"S Schanz","year":"2013","unstructured":"Schanz S, Henes J, Ulmer A et al (2013) Magnetic resonance imaging findings in patients with systemic scleroderma and musculoskeletal symptoms. Eur Radiol 23:212\u2013221","journal-title":"Eur Radiol"},{"key":"1317_CR21","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1093\/rheumatology\/kem088","volume":"46","author":"J Tomasov\u00e1 Studynkov\u00e1","year":"2007","unstructured":"Tomasov\u00e1 Studynkov\u00e1 J, Charv\u00e1t F, Jarosov\u00e1 K, Vencovsky J (2007) The role of MRI in the assessment of polymyositis and dermatomyositis. Rheumatology [Oxford]. 46:1174\u20131179","journal-title":"Rheumatology [Oxford]."},{"key":"1317_CR22","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.2214\/AJR.17.17849","volume":"209","author":"JB Guimaraes","year":"2017","unstructured":"Guimaraes JB, Zanoteli E, Link TM et al (2017) Sporadic Inclusion Body Myositis: MRI Findings and Correlation With Clinical and Functional Parameters. AJR Am J Roentgenol 209:1340\u20131347","journal-title":"AJR Am J Roentgenol"},{"key":"1317_CR23","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1002\/jmri.25196","volume":"44","author":"B Taouli","year":"2016","unstructured":"Taouli B et al (2016) Diffusion-weighted imaging outside the brain: Consensus statement from an ISMRM-sponsored workshop. J Magn Reson Imaging 44:521\u2013540","journal-title":"J Magn Reson Imaging"},{"issue":"6","key":"1317_CR24","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1177\/0284185117731448","volume":"59","author":"HJ Meyer","year":"2017","unstructured":"Meyer HJ, Ziemann O, Kornhuber M et al (2017) Apparent diffusion coefficient [ADC] does not correlate with different serological parameters in myositis and myopathy. Acta Radiol 59(6):694\u2013699","journal-title":"Acta Radiol"},{"issue":"1296\u20131302","key":"1317_CR25","first-page":"7","volume":"263","author":"J Ran","year":"2016","unstructured":"Ran J, Liu Y, Sun D et al (2016) The diagnostic value of biexponential apparent diffusion coefficients in myopathy. J Neurol 263(1296\u20131302):7","journal-title":"J Neurol"},{"key":"1317_CR26","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/jmri.21209","volume":"27","author":"J Qi","year":"2008","unstructured":"Qi J, Olsen NJ, Price RR et al (2008) Diffusion-weighted imaging of inflammatory myopathies: polymyositis and dermatomyositis. J Magn Reson Imaging 27:212\u2013217","journal-title":"J Magn Reson Imaging"},{"key":"1317_CR27","doi-asserted-by":"publisher","first-page":"R209","DOI":"10.1186\/ar4047","volume":"14","author":"S Partovi","year":"2012","unstructured":"Partovi S, Schulte AC, Aschwanden M et al (2012) Impaired skeletal muscle microcirculation in systemic sclerosis. Arthritis Res Ther 14:R209","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"1317_CR28","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/mrm.20953","volume":"56","author":"AM Heemskerk","year":"2006","unstructured":"Heemskerk AM, Drost MR, van Bochove GS et al (2006) DTI-based assessment of ischemia-reperfusion in mouse skeletal muscle. Magn Reson Med 56(2):272\u2013281 (PubMed PMID: 16826605)","journal-title":"Magn Reson Med"}],"container-title":["La radiologia medica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-020-01317-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11547-020-01317-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-020-01317-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,25]],"date-time":"2021-04-25T06:47:50Z","timestamp":1619333270000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11547-020-01317-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,4]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["1317"],"URL":"https:\/\/doi.org\/10.1007\/s11547-020-01317-5","relation":{},"ISSN":["0033-8362","1826-6983"],"issn-type":[{"value":"0033-8362","type":"print"},{"value":"1826-6983","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,4]]},"assertion":[{"value":"12 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Shivani Ahlawat has received support from Department of Defense 2018\u20132023 and Pfizer (2017\u20132018). Laura M. Fayad has received support from GERRAF 2008\u201310 and Siemens 2011\u201312. Julie Paik has received supported in part by Doris Duke Early Clinician Investigator Award, Rheumatology Research Foundation, K Bridge Award, and Stauralaukis Discovery Award. The remaining authors have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Can be made available on request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"This retrospective observational study involving human participants was in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The Human Investigation Committee (IRB) of Johns Hopkins University approved this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The requirement for informed consent was waived.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"N\/A","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}